GAF Healthcare
Specialty Overview

Best Hospitals for Roemheld Syndrome Treatment in India

90 cardiothoracic & vascular surgery hospitals in our India network are listed, across 5 cities (Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai), accredited by JCI, NABH, ISO, NABL, with 51,822 beds combined.

90
Hospitals Listed
5
Cities
4.5
Avg. Rating
5
Accreditation Types
The Short Answer

This page lists the cardiothoracic & vascular surgery hospitals in our directory offering Roemheld Syndrome Treatment in India, including Nanavati Super Specialty Hospital, Apollo Hospitals, Medanta - The Medicity, Artemis Hospital and others. Hospitals are listed across Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai. Each listing links through to the hospital's full profile page.

Including:🇮🇳 Nanavati Super Specialty Hospital🇮🇳 Apollo Hospitals🇮🇳 Medanta - The Medicity

Ask us about roemheld syndrome treatment in India

Share a few details and our care coordination team will get back to you with next steps.

Compare 90 accredited hospitals for Cardiothoracic & Vascular Surgery in India

Nanavati Super Specialty Hospital Featured

🇮🇳 Nanavati Super Specialty Hospital

Mumbai, India 5 (12 reviews) 350 beds
Why consider this hospital?
5/5 rating from 12 reviewsAccredited by JCI, NABH350 beds
Specialties & Accreditation
OncologyCardiac SurgeryNeurosciencesTransplantBariatrics
Accredited by JCI, NABH
5/5
Rating
1950
Established
350
Beds
Mumbai, India
Location
Enquire NowView Profile
Apollo Hospitals

🇮🇳 Apollo Hospitals

New Delhi, India 4.9 (1240 reviews) 1,000 beds
Why consider this hospital?
4.9/5 rating from 1240 reviewsAccredited by JCI, NABH1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH
4.9/5
Rating
1983
Established
1,000
Beds
New Delhi, India
Location
Enquire NowView Profile
Medanta - The Medicity

🇮🇳 Medanta - The Medicity

Gurgaon, India 4.9 (2150 reviews) 1,600 beds
Why consider this hospital?
4.9/5 rating from 2150 reviewsAccredited by JCI, NABH1,600 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH
4.9/5
Rating
2009
Established
1,600
Beds
Gurgaon, India
Location
Enquire NowView Profile
Artemis Hospital

🇮🇳 Artemis Hospital

Gurgaon, India 4.9 (64 reviews) 750 beds
Why consider this hospital?
4.9/5 rating from 64 reviewsAccredited by JCI, NABH750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH
4.9/5
Rating
2007
Established
750
Beds
Gurgaon, India
Location
Enquire NowView Profile
Fortis Memorial Research Institute

🇮🇳 Fortis Memorial Research Institute

Gurgaon, India 4.8 (1100 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1100 reviewsAccredited by JCI, NABH1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
Accredited by JCI, NABH
4.8/5
Rating
1996
Established
1,000
Beds
Gurgaon, India
Location
Enquire NowView Profile
Kokilaben Dhirubhai Ambani Hospital

🇮🇳 Kokilaben Dhirubhai Ambani Hospital

Mumbai, India 4.8 (1800 reviews) 750 beds
Why consider this hospital?
4.8/5 rating from 1800 reviewsAccredited by JCI, NABH750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
Accredited by JCI, NABH
4.8/5
Rating
2009
Established
750
Beds
Mumbai, India
Location
Enquire NowView Profile
Tata Memorial Hospital

🇮🇳 Tata Memorial Hospital

Mumbai, India 4.8 (2500 reviews) 629 beds
Why consider this hospital?
4.8/5 rating from 2500 reviewsAccredited by NABH629 beds
Specialties & Accreditation
OncologyCancer Center
Accredited by NABH
4.8/5
Rating
1941
Established
629
Beds
Mumbai, India
Location
Enquire NowView Profile
Max Super Specialty Hospital

🇮🇳 Max Super Specialty Hospital

New Delhi, India 4.8 (1300 reviews) 500 beds
Why consider this hospital?
4.8/5 rating from 1300 reviewsAccredited by JCI, NABH500 beds
Specialties & Accreditation
CardiacLiver Transplant
Accredited by JCI, NABH
4.8/5
Rating
2000
Established
500
Beds
New Delhi, India
Location
Enquire NowView Profile
Narayana Health

🇮🇳 Narayana Health

Bengaluru, India 4.8 (1750 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1750 reviewsAccredited by NABH1,000 beds
Specialties & Accreditation
CardiacPediatric SurgeryCancer
Accredited by NABH
4.8/5
Rating
2000
Established
1,000
Beds
Bengaluru, India
Location
Enquire NowView Profile
Yashoda Hospitals, Hi-Tech City

🇮🇳 Yashoda Hospitals, Hi-Tech City

Hi-Tech City, Hyderabad, India 4.8 (742 reviews) 2,000 beds
Why consider this hospital?
4.8/5 rating from 742 reviewsAccredited by JCI, NABH2,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsOrgan Transplant
Accredited by JCI, NABH
4.8/5
Rating
1989
Established
2,000
Beds
Hi-Tech City, Hyderabad, India
Location
Enquire NowView Profile
Our Methodology

How we selected these hospitals

A hospital appears on this page when Cardiothoracic & Vascular Surgery is among its listed specialties and it is located in India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Roemheld Syndrome Treatment in India?

Choosing the right hospital for roemheld syndrome treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include cardiothoracic & vascular surgery rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Roemheld Syndrome Treatment

Roemheld Syndrome — a gastrocardiac syndrome in which gastrointestinal distension triggers vagally mediated cardiac arrhythmias, chest pain, and autonomic dysregulation — is managed through a precise combination of dietary, pharmacological, and procedural interventions tailored to each patient's underlying pathophysiology. International outcomes data suggest that symptom resolution is achieved in 75–90% of cases when the root gastrointestinal driver is correctly identified and treated. GAF Healthcare connects international patients with India's and the UAE's most experienced gastroenterology-cardiology multidisciplinary teams, offering diagnostic precision, cost-effective care, and seamless end-to-end medical travel support.

2–5 days (varies by intervention: conservative management vs. endoscopic or surgical procedure)
Hospital Stay
1–3 weeks (depending on whether management is pharmacological only, endoscopic, or laparoscopic/surgical)
Total Stay in Country (Fit-to-Fly)
75–90% (significant symptom reduction or full resolution with correctly targeted multimodal therapy)
Success Rate

Clinical Overview

Roemheld Syndrome (also termed gastrocardiac or gastric-cardiac syndrome) describes a well-documented but frequently under-recognized reflex arc in which excess gas accumulation, hiatal hernia, gastric distension, or elevated intra-abdominal pressure mechanically displaces the diaphragm cephalad, directly compressing the cardiac silhouette and stimulating the vagus nerve. The resulting vagal hyperactivation produces a clinical constellation that may include palpitations, premature atrial or ventricular contractions, supra-ventricular tachycardia (SVT), bradycardia, chest pressure mimicking angina, dyspnea, and profound anxiety or presyncope. Electrocardiographic changes — including ST-segment depression and T-wave inversions — may appear during symptomatic episodes, creating a diagnostic trap that leads many patients through unnecessary cardiac workups for years before the gastric etiology is identified.

Full details →

Who is a Candidate?

  • ELIGIBLE PATIENTS:
  • Adults with recurrent, unexplained palpitations, arrhythmias, or chest pain in whom primary cardiac disease has been ruled out by cardiology evaluation
  • Patients with a confirmed or suspected hiatal hernia (Type I–IV) who experience cardiac symptoms temporally associated with meals, postprandial bloating, or positional changes
  • Individuals with documented aerophagia, SIBO, gastroparesis, or IBS with coincident episodic arrhythmias (PACs, PVCs, SVT, or AF)
  • Patients with persistent symptoms despite empirical proton-pump inhibitor (PPI) or antacid therapy who have not received a formal Roemheld Syndrome evaluation
  • +20 more

Treatment Options & Approaches

Treatment for Roemheld Syndrome is individualized based on the identified primary GI driver, arrhythmia burden, and anatomical findings. A stepwise escalation model is employed by GAF Healthcare's partner MDT teams.

STEP 1 — DIETARY, BEHAVIORAL & LIFESTYLE MODIFICATION (All patients; first-line):

Elimination of gas-producing foods (FODMAPs, carbonated beverages, cruciferous vegetables), eating smaller and more frequent meals, avoidance of reclining within 3 hours of meals, weight optimization, and diaphragmatic breathing retraining. Behavioral therapy for aerophagia (a recognized trigger) includes speech therapy techniques and biofeedback. These measures alone resolve symptoms in approximately 20–30% of mild cases.

STEP 2 — PHARMACOLOGICAL MANAGEMENT (Moderate cases):

Full details →

Recovery

PRE-ARRIVAL (2–4 weeks before travel):

  • GAF Healthcare coordinator collects medical records, prior ECGs, endoscopy reports, and imaging for remote MDT review.
  • Indian e-Medical Visa or UAE entry visa facilitated by GAF Healthcare's dedicated visa assistance team.
  • Tailored treatment plan and cost estimate issued in writing; pre-travel dietary guidelines for GI preparation dispatched to the patient.

DAY 1 — Arrival & Initial ASSESSMENT:

Full details →

Risks to be aware of

Roemheld Syndrome management carries a risk profile that varies substantially by treatment modality. For pharmacological management, risks are generally low: PPIs carry a small long-term risk of hypomagnesemia, C. difficile susceptibility, and reduced bone mineral density with multi-year use; Rifaximin (for SIBO) is well-tolerated but carries a <1% risk of Clostridium difficile colitis; prokinetics such as Metoclopramide carry a risk of tardive dyskinesia with prolonged use and should be limited to short courses. For endoscopic procedures (TIF 2.0, G-POEM), risks include mucosal perforation (1–2%), post-procedural bleeding requiring endoscopic hemostasis (<2%), mediastinal emphysema, and aspiration pneumonia under anesthesia. Symptom recurrence rates for endoscopic hiatal reduction are higher than for surgical repair, estimated at 15–25% at 3 years. For laparoscopic and robotic hiatal hernia repair and fundoplication, the most clinically significant risks include: post-fundoplication dysphagia (5–15%, usually transient and resolving within 6–12 weeks with dietary progression; persistent dysphagia requiring endoscopic balloon dilation in approximately 3–5% of patients); gas-bloat syndrome (inability to belch or vomit, in 10–20% — often self-limiting); wrap migration or herniation recurrence (3–8% at 5 years, higher with large para-esophageal hernias); inadvertent esophageal or gastric perforation (<1%); and vagal nerve injury causing accelerated gastric emptying or diarrhea. General surgical risks include venous thromboembolism (mitigated with LMWH prophylaxis), pulmonary complications, and port-site hernia. Patients should be counselled that arrhythmia resolution, while expected in 75–90% of cases, is not guaranteed if additional non-gastric contributors to the arrhythmia are present (e.g., co-existing channelopathy or structural cardiac disease). All risks are systematically reviewed with the patient by the treating MDT at GAF Healthcare's partner hospitals prior to written informed consent.

Why GAF Healthcare

GAF Healthcare provides comprehensive, concierge-level medical travel coordination for all Roemheld Syndrome patients traveling to India or the UAE, addressing every non-clinical aspect of the journey.

Common questions about Roemheld Syndrome Treatment

What is the cost of Roemheld Syndrome treatment in India compared to the UAE?
The total cost of Roemheld Syndrome management — encompassing the full diagnostic workup and the selected treatment pathway — typically ranges from USD 2,500 to USD 9,000 in India and from USD 5,500 to USD 18,000 in the UAE (Dubai or Abu Dhabi). The lower end of both ranges reflects a purely pharmacological management program (diagnostic tests, specialist consultations, and prescribed medications), while the upper end represents complex robotic-assisted laparoscopic para-esophageal hernia repair with fundoplication at a premium JCI-accredited hospital. India offers equivalent clinical quality at approximately 40–60% lower cost than the UAE, making it the preferred destination for cost-sensitive patients. UAE facilities offer shorter waiting times, English-language environments, premium hospitality, and proximity for Middle Eastern and European patients. Both destinations include JCI-accredited partner hospitals. These figures exclude international airfare and personal expenses. GAF Healthcare provides a fully itemized written cost estimate before any commitment is required.
How long do I need to stay in the country before I am fit to fly home after Roemheld Syndrome treatment?
The required in-country stay depends directly on the treatment pathway followed. For patients managed conservatively with pharmacological therapy and dietary counselling only, a stay of 7–14 days is typically sufficient — allowing time for the full diagnostic workup (approximately 3–5 days) and a short observation period to confirm initial treatment response before flying. For patients who undergo an endoscopic procedure such as Transoral Incisionless Fundoplication (TIF 2.0) or G-POEM pyloromyotomy, a minimum stay of 14–18 days post-procedure is recommended before long-haul flying, to allow mucosal healing and confirm the absence of delayed complications. For patients undergoing laparoscopic or robotic-assisted hiatal hernia repair with fundoplication — the most anatomically definitive intervention — the treating surgical team will issue fit-to-fly clearance no earlier than 14 days and more typically 18–21 days post-operatively, subject to clinical review. This timeline accounts for the resolution of any intra-abdominal gas (which expands at altitude and can cause discomfort in a pressurized cabin), confirmation of stable cardiac rhythm on repeat Holter monitoring, and adequate dietary advancement. GAF Healthcare's case manager coordinates the formal fit-to-fly letter from the treating surgeon, which is required by most international airlines for post-surgical travel.
What is the success rate of Roemheld Syndrome treatment?
The overall success rate for Roemheld Syndrome treatment — defined as significant reduction or complete resolution of cardiac symptoms (palpitations, arrhythmias, chest pain) attributable to the gastrocardiac reflex — is approximately 75–90% when the correct primary gastrointestinal driver is identified and appropriately treated. For patients with a confirmed large hiatal hernia (Type II–IV para-esophageal hernia) treated with laparoscopic or robotic fundoplication and crural repair, arrhythmia resolution rates exceed 80–85% in published case series, with durable outcomes at 5 years. For patients with SIBO as the primary driver treated with Rifaximin-based eradication therapy, symptomatic improvement rates of 70–80% are reported, though SIBO recurrence rates of 30–40% at 12 months necessitate a maintenance management strategy. For mild-to-moderate cases managed with dietary modification, prokinetics, and PPIs alone, approximately 20–30% achieve full resolution and a further 40–50% achieve meaningful improvement. The remaining 10–25% may require escalation to endoscopic or surgical intervention. Outcomes are less predictable in patients with co-existing primary cardiac arrhythmia, significant autonomic neuropathy, or untreated anxiety disorder — which is why GAF Healthcare's partner MDT teams conduct comprehensive cardiology and psychiatric screening before finalizing the treatment plan. All success rate data cited is based on peer-reviewed gastroenterology and cardiothoracic surgery literature and reflects outcomes at high-volume centers.

Related pages

How GAF Healthcare Assists in Choosing the Best Hospital for Roemheld Syndrome Treatment in India

Discover the Top Hospitals for Roemheld Syndrome Treatment in India

This page lists 90 accredited cardiothoracic & vascular surgery hospitals in India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about roemheld syndrome treatment in India

How many cardiothoracic & vascular surgery hospitals are listed in India?
90 hospitals in our India directory are currently listed for cardiothoracic & vascular surgery including Roemheld Syndrome Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Cardiothoracic & Vascular Surgery is among its listed specialties and it is located in India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Which cities in India have cardiothoracic & vascular surgery hospitals listed?
Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai. Use the city links on this page to view hospitals in a specific city.
🤔

Still have questions?

Our coordinators are here to answer your questions about roemheld syndrome treatment in India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for roemheld syndrome treatment in India.

Contact us to report an inaccuracy on this page.

WhatsApp Us